Order Article Reprints

McCurdy A, Venner CP, Masih-Khan E, Louzada M, LeBlanc R, Sebag M, Song K, Jimenez-Zepeda VH, Kotb R, Kardjadj M, et al. Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database. Current Oncology. 2022; 29(3):1575-1582. https://doi.org/10.3390/curroncol29030132

McCurdy, Arleigh, Christopher P. Venner, Esther Masih-Khan, Martha Louzada, Richard LeBlanc, Michael Sebag, Kevin Song, Victor H. Jimenez-Zepeda, Rami Kotb, Moustafa Kardjadj, and et al. 2022. "Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database" Current Oncology 29, no. 3: 1575-1582. https://doi.org/10.3390/curroncol29030132

McCurdy, A., Venner, C. P., Masih-Khan, E., Louzada, M., LeBlanc, R., Sebag, M., Song, K., Jimenez-Zepeda, V. H., Kotb, R., Kardjadj, M., Mian, H., White, D., Stakiw, J., Aslam, M., Reiman, A., Gul, E., & Reece, D. (2022). Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database. Current Oncology, 29(3), 1575-1582. https://doi.org/10.3390/curroncol29030132